
|Articles|October 29, 2013
PhRMA on Leveling the Playing Field for Innovation
Robert Hugin, Chairman of Celgene and PhRMA, talks about the challenges ahead for the industry organization
Advertisement
Robert Hugin, Chairman of Celgene and PhRMA, talks about the challenges ahead for the industry organization.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Datroway for Patients with Metastatic Triple-Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Candidates
2
What Kinds of Disruption are GLP-1s Expected to Face
3
Eli Lilly and Novo Nordisk Shift Patients From Compounded Drugs to Lower-Cost Weight-Loss Pills: Report
4
The Evolving Relationship Between FDA and Biotech
5




